BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17403849)

  • 1. Antifungal therapy in children with invasive fungal infections: a systematic review.
    Blyth CC; Palasanthiran P; O'Brien TA
    Pediatrics; 2007 Apr; 119(4):772-84. PubMed ID: 17403849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
    Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
    Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal management in cancer patients.
    Staber P; Langner S; Dornbusch HJ; Neumeister P
    Wien Med Wochenschr; 2007; 157(19-20):503-10. PubMed ID: 18030555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive fungal infections in pediatric patients: a review focusing on antifungal therapy.
    Lass-Flörl C
    Expert Rev Anti Infect Ther; 2010 Feb; 8(2):127-35. PubMed ID: 20109043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best practice in treating infants and children with proven, probable or suspected invasive fungal infections.
    Katragkou A; Roilides E
    Curr Opin Infect Dis; 2011 Jun; 24(3):225-9. PubMed ID: 21455060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination antifungal therapy.
    Patterson TF
    Pediatr Infect Dis J; 2003 Jun; 22(6):555-6. PubMed ID: 12799514
    [No Abstract]   [Full Text] [Related]  

  • 8. Invasive fungal infections in the intensive care unit.
    Vazquez JA
    Semin Respir Crit Care Med; 2010 Feb; 31(1):79-86. PubMed ID: 20101550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and management of fungal infections and pneumocystis pneumonitis in pediatric cancer patients].
    Groll AH; Ritter J
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S37-66. PubMed ID: 16288352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empiric antifungal therapy in patients with febrile neutropenia.
    Ferrara JJ; MacDougall C; Gallagher JC
    Pharmacotherapy; 2011 Apr; 31(4):369-85. PubMed ID: 21449626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive fungal infections: evolving challenges for diagnosis and therapeutics.
    Ellis M
    Mol Immunol; 2002 May; 38(12-13):947-57. PubMed ID: 12009573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients.
    Zaoutis TE; Jafri HS; Huang LM; Locatelli F; Barzilai A; Ebell W; Steinbach WJ; Bradley J; Lieberman JM; Hsiao CC; Seibel N; Laws HJ; Gamba M; Petrecz M; Taylor AF; Strohmaier KM; Chow JW; Kartsonis NA; Ngai AL
    Pediatrics; 2009 Mar; 123(3):877-84. PubMed ID: 19255017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].
    Salavert-Lletí M; Zaragoza-Crespo R
    Rev Iberoam Micol; 2009 Mar; 26(1):81-9. PubMed ID: 19463284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspofungin acetate for treatment of invasive fungal infections.
    Pacetti SA; Gelone SP
    Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An epidemic of invasive fungal infection in a stem cell transplant unit; response to high-dose liposomal amphotericin B.
    Ryan C; McNicholsan S; O'Connell B; Forde S; Keoghan M; McCann SR
    Hematol J; 2004; 5(6):548-51. PubMed ID: 15570304
    [No Abstract]   [Full Text] [Related]  

  • 17. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
    Keating G; Figgitt D
    Drugs; 2003; 63(20):2235-63. PubMed ID: 14498760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of newer antifungal therapies in clinical practice: what do the data tell us?
    Perfect JR
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antifungal therapy update: new drugs and medical uses].
    Fortún J
    Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():38-44. PubMed ID: 22305668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric antifungal therapy. Part I: focus on febrile neutropenia, invasive aspergillosis, combination antifungal therapy and invasive candidiasis in immunocompromised pediatric patients.
    Allen U; Bow E; Doyle J; Richardson S; Robinson J; Rotstein C; Davies D; Hui C; Le Saux N; Laverdiere M; Read S
    Minerva Pediatr; 2010 Feb; 62(1):57-69. PubMed ID: 20212399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.